Marker Therapeutics Inc (MRKR) financials · rev $3.5M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Marker Therapeutics Inc (MRKR) rev $3.5M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $3.55M | $6.59M |
| Operating Income | -$12.9M | -$11.1M |
| Net Income | -$12.2M | -$10.7M |
| EPS (Diluted) | -$0.79 | -$1.19 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $19.1M | $22.0M |
| Current Assets | $19.1M | $22.0M |
| Cash & Equivalents | $16.1M | $19.2M |
| Total Liabilities | $2.27M | $3.46M |
| Current Liabilities | $2.27M | $3.46M |
| Shareholders' Equity | $16.8M | $18.6M |
| Retained Earnings | -$459.2M | -$447.0M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$12.0M | -$10.9M |
| Financing Cash Flow | $9.86M | $15.0M |
FAQ
What is MRKR P/E and revenue?
Marker Therapeutics Inc (MRKR) rev $3.5M.
What is MRKR revenue?
Marker Therapeutics Inc last cached revenue is $3.55M (FY2025).
Is MRKR profitable?
Marker Therapeutics Inc last cached net income is -$12.2M (FY2025).
What are MRKR total assets?
Marker Therapeutics Inc last cached total assets are $19.1M (FY2025).
What is MRKR free cash flow?
No cached cash-flow row for MRKR yet.
Not investment advice. Cached statements, not a live tape.